List your tool

8 alternatives · updated Aug 2026

The best Unlearn.AI alternatives in 2026

8 tools that do the job Unlearn.AI does. Each one is measured against Unlearn.AI on price, free plan and our rating, so you can see what you gain by switching.

Shortlist by what you need

Start here if you know why you are leaving Unlearn.AI.

  1. Want the closest match?

    Immunai

    Most similar to Unlearn.AI in what it does, its category and its price.

    Visit (opens Immunai in a new tab)
  2. Want the best rated?

    Qureight

    Rated 4.1 out of 5 in our review, against 4.2 for Unlearn.AI.

    Visit (opens Qureight in a new tab)

At a glance

Green means better than Unlearn.AI, red means worse. Prices are starting prices per month.

ToolOur ratingStarts atFree planBest forCompare
Unlearn.AIBaseline4.2Not listedNoDigital twins of trial participants that shrink the control arm by about a third.
Immunai4.0−0.2Not listedNoAI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners.vs Unlearn.AI
Qureight4.1−0.1Not listedNoImaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab.vs Unlearn.AI
QuantHealth4.1−0.1Not listedNoClinical trial simulation platform for predicting patient response to therapiesvs Unlearn.AI
Narrativa3.6−0.6Not listedNoAgentic AI generates compliant clinical study reports, patient narratives, and regulatory submissions at scale - GxP-ready, GDPR-aligned, and built to an FDA/EMA-aligned safety framework.vs Unlearn.AI
NetraMark3.8−0.4Not listedNoNetraAI analyses clinical trial data to optimise trial design - finding optimal dosage, identifying ideal patient populations and increasing effect size.vs Unlearn.AI
MDClone4.1−0.1Not listedNoHealthcare data platform that generates synthetic patient data for privacy-safe research and analytics.vs Unlearn.AI
RagaAI3.9−0.3Not listedNoProduction-grade agent suites for healthcare, built on its own evaluation platforms.vs Unlearn.AI
ThriveLink3.7−0.5Not listedNoTelephonic AI enrolment that helps people sign up for social benefit programs by phone.vs Unlearn.AI

The alternatives in detail

In order of how closely each one matches Unlearn.AI.

  1. Immunai

    4.0Not listed

    vs Unlearn.AI−0.2

    AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners.

    • AMICA-OS platform built on single-cell multi-omic immune system data
    • Target discovery tools for identifying new drug candidates from immune cell behavior
    • Preclinical evaluation modeling for testing target hypotheses before trials

    Dataset scale, built through partnerships with Fortune 100 pharma companies, gives its models depth smaller labs can't replicate

    No published pricing; every engagement is a custom partnership negotiation

  2. Qureight

    4.1Not listed

    vs Unlearn.AI−0.1

    Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab.

    • Deep-learning lung imaging biomarkers Lung8, Air8 and Fibr8
    • Glass8 and Vascul8 for vascular and parenchymal measures
    • Central reads and endpoint discovery for trials

    Consistent measurement reduces the variability that costs trial power

    No published pricing; sold to trial sponsors

  3. QuantHealth

    4.1Not listed

    vs Unlearn.AI−0.1

    Clinical trial simulation platform for predicting patient response to therapies.

    • In-silico simulation of clinical trial outcomes
    • Patient response prediction across therapy candidates
    • Protocol testing before a trial is committed

    Tests expensive protocol decisions before commitment

    Credibility depends on retrospective validation in the same indication

  4. Narrativa

    3.6Not listed

    vs Unlearn.AI−0.6

    Agentic AI generates compliant clinical study reports, patient narratives, and regulatory submissions at scale - GxP-ready, GDPR-aligned, and built to an FDA/EMA-aligned safety framework.

    • Agentic AI generates clinical study reports and patient narratives
    • Knowledge graph technology for complex clinical relationships
    • GxP-ready validation architecture

    Purpose-built compliance architecture (GxP/FDA/EMA-aligned), not generic enterprise AI

    No published pricing - an enterprise sales process

  5. NetraMark

    3.8Not listed

    vs Unlearn.AI−0.4

    NetraAI analyses clinical trial data to optimise trial design - finding optimal dosage, identifying ideal patient populations and increasing effect size.

    • NetraAI platform for clinical trial design optimisation
    • Optimal dosage discovery from trial data
    • Identification of ideal treatment populations

    Targets the design decisions that determine whether a trial succeeds

    No public pricing - enterprise pharma engagement

  6. MDClone

    4.1Not listed

    vs Unlearn.AI−0.1

    Healthcare data platform that generates synthetic patient data for privacy-safe research and analytics.

    • Synthetic patient data generation preserving real statistical patterns
    • Self-service query and exploration environment for non-technical analysts
    • Real-time access to large-scale healthcare datasets

    Synthetic-data approach sidesteps lengthy IRB and de-identification review cycles

    No public pricing, with enterprise sales cycles typical of hospital software

  7. RagaAI

    3.9Not listed

    vs Unlearn.AI−0.3

    Production-grade agent suites for healthcare, built on its own evaluation platforms.

    • Agent suites for healthcare, life sciences and aerospace
    • Built on the RagaAI Prism and Catalyst platforms
    • Radiology, allergy and clinical trial deployments

    Owns the evaluation stack the agents are judged with

    Demo-only pricing with nothing published

FAQ

Questions people ask

Is Unlearn.AI free?

Unlearn.AI does not list a free plan. Check its pricing page for current plans.

How did you pick these alternatives?

We match tools on what they do, their category and their price, using the details in our directory. Ratings come from our reviews and reader reviews.